BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fernandez CA, Smith C, Yang W, Mullighan CG, Qu C, Larsen E, Bowman WP, Liu C, Ramsey LB, Chang T, Karol SE, Loh ML, Raetz EA, Winick NJ, Hunger SP, Carroll WL, Jeha S, Pui CH, Evans WE, Devidas M, Relling MV. Genome-wide analysis links NFATC2 with asparaginase hypersensitivity. Blood 2015;126:69-75. [PMID: 25987655 DOI: 10.1182/blood-2015-02-628800] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 6.6] [Reference Citation Analysis]
Number Citing Articles
1 Kutszegi N, Semsei ÁF, Gézsi A, Sági JC, Nagy V, Csordás K, Jakab Z, Lautner-Csorba O, Gábor KM, Kovács GT, Erdélyi DJ, Szalai C. Subgroups of Paediatric Acute Lymphoblastic Leukaemia Might Differ Significantly in Genetic Predisposition to Asparaginase Hypersensitivity. PLoS One 2015;10:e0140136. [PMID: 26457809 DOI: 10.1371/journal.pone.0140136] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
2 Burke MJ, Zalewska-Szewczyk B. Hypersensitivity reactions to asparaginase therapy in acute lymphoblastic leukemia: immunology and clinical consequences. Future Oncol 2022. [PMID: 35107320 DOI: 10.2217/fon-2021-1288] [Reference Citation Analysis]
3 Lauschke VM, Zhou Y, Ingelman-Sundberg M. Novel genetic and epigenetic factors of importance for inter-individual differences in drug disposition, response and toxicity. Pharmacol Ther 2019;197:122-52. [PMID: 30677473 DOI: 10.1016/j.pharmthera.2019.01.002] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 10.0] [Reference Citation Analysis]
4 Sayitoğlu M. Clinical Interpretation of Genomic Variations. Turk J Haematol 2016;33:172-9. [PMID: 27507302 DOI: 10.4274/tjh.2016.0149] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
5 Asselin B. Immunology of infusion reactions in the treatment of patients with acute lymphoblastic leukemia. Future Oncology 2016;12:1609-21. [DOI: 10.2217/fon-2016-0005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
6 Gagné V, St-Onge P, Beaulieu P, Laverdière C, Leclerc JM, Tran TH, Sallan SE, Neuberg D, Silverman LB, Sinnett D, Krajinovic M. HLA alleles associated with asparaginase hypersensitivity in childhood ALL: a report from the DFCI Consortium. Pharmacogenomics 2020;21:541-7. [PMID: 32372697 DOI: 10.2217/pgs-2019-0195] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
7 Yu CH, Chang YH, Wang DS, Jou ST, Lin CY, Lin KH, Lu MY, Raghav L, Chang HH, Wu KH, Chou SW, Ni YL, Lin DT, Lin SW, Chen HY, Yang YL. Determination of NUDT15 variants by targeted sequencing can identify compound heterozygosity in pediatric acute lymphoblastic leukemia patients. Sci Rep 2020;10:14400. [PMID: 32873882 DOI: 10.1038/s41598-020-71468-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Moriyama T, Yang YL, Nishii R, Ariffin H, Liu C, Lin TN, Yang W, Lin DT, Yu CH, Kham S, Pui CH, Evans WE, Jeha S, Relling MV, Yeoh AE, Yang JJ. Novel variants in NUDT15 and thiopurine intolerance in children with acute lymphoblastic leukemia from diverse ancestry. Blood. 2017;130:1209-1212. [PMID: 28659275 DOI: 10.1182/blood-2017-05-782383] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 10.8] [Reference Citation Analysis]
9 Maxwell RR, Cole PD. Pharmacogenetic Predictors of Treatment-Related Toxicity Among Children With Acute Lymphoblastic Leukemia. Curr Hematol Malig Rep 2017;12:176-86. [DOI: 10.1007/s11899-017-0376-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
10 Maia A, Sammut S, Jacinta-fernandes A, Chin S. Big data in cancer genomics. Current Opinion in Systems Biology 2017;4:78-84. [DOI: 10.1016/j.coisb.2017.07.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 2.2] [Reference Citation Analysis]
11 Zhang G, Nebert DW. Personalized medicine: Genetic risk prediction of drug response. Pharmacol Ther 2017;175:75-90. [PMID: 28213088 DOI: 10.1016/j.pharmthera.2017.02.036] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
12 Rathod S, Ramsey M, Finkelman FD, Fernandez CA. Genetic inhibition of NFATC2 attenuates asparaginase hypersensitivity in mice. Blood Adv 2020;4:4406-16. [PMID: 32931581 DOI: 10.1182/bloodadvances.2020002478] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
13 Robinson KM, Yang W, Karol SE, Kornegay N, Jay D, Cheng C, Choi JK, Campana D, Pui CH, Wood B, Borowitz MJ, Gastier-Foster J, Larsen EC, Winick N, Carroll WL, Loh ML, Raetz EA, Hunger SP, Devidas M, Mardis ER, Fulton RS, Relling MV, Jeha S. No evidence that G6PD deficiency affects the efficacy or safety of daunorubicin in acute lymphoblastic leukemia induction therapy. Pediatr Blood Cancer 2019;66:e27681. [PMID: 30848065 DOI: 10.1002/pbc.27681] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
14 Lopez-Santillan M, Iparraguirre L, Martin-Guerrero I, Gutierrez-Camino A, Garcia-Orad A. Review of pharmacogenetics studies of L-asparaginase hypersensitivity in acute lymphoblastic leukemia points to variants in the GRIA1 gene. Drug Metab Pers Ther 2017;32:1-9. [PMID: 28259867 DOI: 10.1515/dmpt-2016-0033] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
15 Maese L, Rau RE. Current Use of Asparaginase in Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma. Front Pediatr 2022;10:902117. [DOI: 10.3389/fped.2022.902117] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Finch ER, Smith CA, Yang W, Liu Y, Kornegay NM, Panetta JC, Crews KR, Molinelli AR, Cheng C, Pei D, Ramsey LB, Karol SE, Inaba H, Sandlund JT, Metzger M, Evans WE, Jeha S, Pui CH, Relling MV. Asparaginase formulation impacts hypertriglyceridemia during therapy for acute lymphoblastic leukemia. Pediatr Blood Cancer 2020;67:e28040. [PMID: 31612640 DOI: 10.1002/pbc.28040] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
17 Iannuzzi A, Annunziata M, Fortunato G, Giacobbe C, Palma D, Bresciani A, Aliberti E, Iannuzzo G. Case Report: Genetic Analysis of PEG-Asparaginase Induced Severe Hypertriglyceridemia in an Adult With Acute Lymphoblastic Leukaemia. Front Genet 2022;13:832890. [DOI: 10.3389/fgene.2022.832890] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Schmiegelow K, Müller K, Mogensen SS, Mogensen PR, Wolthers BO, Stoltze UK, Tuckuviene R, Frandsen T. Non-infectious chemotherapy-associated acute toxicities during childhood acute lymphoblastic leukemia therapy. F1000Res 2017;6:444. [PMID: 28413626 DOI: 10.12688/f1000research.10768.1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 5.4] [Reference Citation Analysis]
19 Place AE, Stevenson KE, Vrooman LM, Harris MH, Hunt SK, O'Brien JE, Supko JG, Asselin BL, Athale UH, Clavell LA, Cole PD, Kelly KM, Laverdiere C, Leclerc JM, Michon B, Schorin MA, Welch JJ, Lipshultz SE, Kutok JL, Blonquist TM, Neuberg DS, Sallan SE, Silverman LB. Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial. Lancet Oncol 2015;16:1677-90. [PMID: 26549586 DOI: 10.1016/S1470-2045(15)00363-0] [Cited by in Crossref: 119] [Cited by in F6Publishing: 66] [Article Influence: 17.0] [Reference Citation Analysis]
20 Liu Y, Smith CA, Panetta JC, Yang W, Thompson LE, Counts JP, Molinelli AR, Pei D, Kornegay NM, Crews KR, Swanson H, Cheng C, Karol SE, Evans WE, Inaba H, Pui CH, Jeha S, Relling MV. Antibodies Predict Pegaspargase Allergic Reactions and Failure of Rechallenge. J Clin Oncol 2019;37:2051-61. [PMID: 31188727 DOI: 10.1200/JCO.18.02439] [Cited by in Crossref: 28] [Cited by in F6Publishing: 12] [Article Influence: 9.3] [Reference Citation Analysis]
21 Rau RE, Loh ML. Using genomics to define pediatric blood cancers and inform practice. Hematology Am Soc Hematol Educ Program 2018;2018:286-300. [PMID: 30504323 DOI: 10.1182/asheducation-2018.1.286] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
22 Moriyama T, Metzger ML, Wu G, Nishii R, Qian M, Devidas M, Yang W, Cheng C, Cao X, Quinn E, Raimondi S, Gastier-Foster JM, Raetz E, Larsen E, Martin PL, Bowman WP, Winick N, Komada Y, Wang S, Edmonson M, Xu H, Mardis E, Fulton R, Pui CH, Mullighan C, Evans WE, Zhang J, Hunger SP, Relling MV, Nichols KE, Loh ML, Yang JJ. Germline genetic variation in ETV6 and risk of childhood acute lymphoblastic leukaemia: a systematic genetic study. Lancet Oncol 2015;16:1659-66. [PMID: 26522332 DOI: 10.1016/S1470-2045(15)00369-1] [Cited by in Crossref: 110] [Cited by in F6Publishing: 53] [Article Influence: 15.7] [Reference Citation Analysis]
23 Di Paolo A, Arrigoni E, Luci G, Cucchiara F, Danesi R, Galimberti S. Precision Medicine in Lymphoma by Innovative Instrumental Platforms. Front Oncol 2019;9:1417. [PMID: 31921674 DOI: 10.3389/fonc.2019.01417] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
24 Yu LL, Zhang W, Li J, Zhao L. Association between CYP2B6 polymorphism and acute leukemia in a Han population of Northwest China. Mol Genet Genomic Med 2020;8:e1162. [PMID: 32119768 DOI: 10.1002/mgg3.1162] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Wang Z, Yang H, Si S, Han Z, Tao J, Chen H, Ge Y, Guo M, Wang K, Tan R, Wei JF, Gu M. Polymorphisms of nucleotide factor of activated T cells cytoplasmic 2 and 4 and the risk of acute rejection following kidney transplantation. World J Urol 2018;36:111-6. [PMID: 29103109 DOI: 10.1007/s00345-017-2117-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
26 Xu Q, Qiu X, Jiao Z, Zhang M, Chen J, Zhong M. NFATC1 genotypes affect acute rejection and long-term graft function in cyclosporine-treated renal transplant recipients. Pharmacogenomics 2017;18:381-92. [PMID: 28244807 DOI: 10.2217/pgs-2016-0171] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
27 Chua GT, Rosa Duque JS, Cheuk DKL, Leung AWK, Wong WHS, Liu APY, Lee PPW, Ha SY, Chiang AKS, Ho MHK, Chu WK, Chan YS, Luk CW, Ling ASC, Kwan MYW, Yiu OKF, Wong ICK, Lau YL, Li CK, Leung WH, Chan GCF, Ip P, Kwok J. HLA alleles associated with asparaginase hypersensitivity in Chinese children. J Hematol Oncol 2021;14:182. [PMID: 34717720 DOI: 10.1186/s13045-021-01201-3] [Reference Citation Analysis]
28 Karol SE, Larsen E, Cheng C, Cao X, Yang W, Ramsey LB, Fernandez CA, McCorkle JR, Paugh SW, Autry RJ, Lopez-Lopez E, Diouf B, Jeha S, Pui CH, Raetz EA, Winick NJ, Carroll WL, Hunger SP, Loh ML, Devidas M, Evans WE, Yang JJ, Relling MV. Genetics of ancestry-specific risk for relapse in acute lymphoblastic leukemia. Leukemia 2017;31:1325-32. [PMID: 28096535 DOI: 10.1038/leu.2017.24] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
29 Burke MJ, Rheingold SR. Differentiating hypersensitivity versus infusion-related reactions in pediatric patients receiving intravenous asparaginase therapy for acute lymphoblastic leukemia. Leukemia & Lymphoma 2016;58:540-51. [DOI: 10.1080/10428194.2016.1213826] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
30 Zhong S, Wei H, Li M, Cheng Y, Wen S, Wang D, Shu Y. Single Nucleotide Polymorphisms in the Human Leukocyte Antigen Region Are Associated With Hemagglutination Inhibition Antibody Response to Influenza Vaccine. Front Genet 2022;13:790914. [DOI: 10.3389/fgene.2022.790914] [Reference Citation Analysis]
31 Qian M, Cao X, Devidas M, Yang W, Cheng C, Dai Y, Carroll A, Heerema NA, Zhang H, Moriyama T, Gastier-Foster JM, Xu H, Raetz E, Larsen E, Winick N, Bowman WP, Martin PL, Mardis ER, Fulton R, Zambetti G, Borowitz M, Wood B, Nichols KE, Carroll WL, Pui CH, Mullighan CG, Evans WE, Hunger SP, Relling MV, Loh ML, Yang JJ. TP53 Germline Variations Influence the Predisposition and Prognosis of B-Cell Acute Lymphoblastic Leukemia in Children. J Clin Oncol 2018;36:591-9. [PMID: 29300620 DOI: 10.1200/JCO.2017.75.5215] [Cited by in Crossref: 71] [Cited by in F6Publishing: 42] [Article Influence: 17.8] [Reference Citation Analysis]
32 Wertman JN, Dunn KA, Kulkarni K. The impact of the host intestinal microbiome on carcinogenesis and the response to chemotherapy. Future Oncol 2021;17:4371-87. [PMID: 34448411 DOI: 10.2217/fon-2021-0087] [Reference Citation Analysis]
33 Boissel N, Sender LS. Best Practices in Adolescent and Young Adult Patients with Acute Lymphoblastic Leukemia: A Focus on Asparaginase. J Adolesc Young Adult Oncol 2015;4:118-28. [PMID: 26421220 DOI: 10.1089/jayao.2015.0014] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 5.3] [Reference Citation Analysis]
34 Abaji R, Krajinovic M. Current perspective on pediatric pharmacogenomics. Expert Opin Drug Metab Toxicol 2016;12:363-5. [PMID: 26799591 DOI: 10.1517/17425255.2016.1145656] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
35 Khor SS, Morino R, Nakazono K, Kamitsuji S, Akita M, Kawajiri M, Yamasaki T, Kami A, Hoshi Y, Tada A, Ishikawa K, Hine M, Kobayashi M, Kurume N, Kamatani N, Tokunaga K, Johnson TA. Genome-wide association study of self-reported food reactions in Japanese identifies shrimp and peach specific loci in the HLA-DR/DQ gene region. Sci Rep 2018;8:1069. [PMID: 29348432 DOI: 10.1038/s41598-017-18241-w] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
36 Franca R, Zudeh G, Lucafò M, Rabusin M, Decorti G, Stocco G. Genome wide association studies for treatment-related adverse effects of pediatric acute lymphoblastic leukemia. Wiley Interdiscip Rev Syst Biol Med 2020;:e1509. [PMID: 33016644 DOI: 10.1002/wsbm.1509] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
37 Ibáñez M, Carbonell-Caballero J, Such E, García-Alonso L, Liquori A, López-Pavía M, Llop M, Alonso C, Barragán E, Gómez-Seguí I, Neef A, Hervás D, Montesinos P, Sanz G, Sanz MA, Dopazo J, Cervera J. The modular network structure of the mutational landscape of Acute Myeloid Leukemia. PLoS One 2018;13:e0202926. [PMID: 30303964 DOI: 10.1371/journal.pone.0202926] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
38 Waespe N, Strebel S, Nava T, Uppugunduri CRS, Marino D, Mattiello V, Otth M, Gumy-pause F, Von Bueren AO, Baleydier F, Mader L, Spoerri A, Kuehni CE, Ansari M. Cohort-based association study of germline genetic variants with acute and chronic health complications of childhood cancer and its treatment: Genetic Risks for Childhood Cancer Complications Switzerland (GECCOS) study protocol. BMJ Open 2022;12:e052131. [DOI: 10.1136/bmjopen-2021-052131] [Reference Citation Analysis]
39 Shinohara T, Urayama KY, Watanabe A, Akahane K, Goi K, Huang M, Kagami K, Abe M, Sugita K, Okada Y, Goto H, Minegishi M, Iwamoto S, Inukai T. Inherited genetic variants associated with glucocorticoid sensitivity in leukaemia cells. J Cell Mol Med 2020;24:12920-32. [PMID: 33002292 DOI: 10.1111/jcmm.15882] [Reference Citation Analysis]
40 Khan DA, Banerji A, Bernstein JA, Bilgicer B, Blumenthal K, Castells M, Ein D, Lang DM, Phillips E. Cephalosporin Allergy: Current Understanding and Future Challenges. J Allergy Clin Immunol Pract 2019;7:2105-14. [PMID: 31495420 DOI: 10.1016/j.jaip.2019.06.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 11.5] [Reference Citation Analysis]
41 Rathod S, Ramsey M, Relling MV, Finkelman FD, Fernandez CA. Hypersensitivity reactions to asparaginase in mice are mediated by anti-asparaginase IgE and IgG and the immunoglobulin receptors FcεRI and FcγRIII. Haematologica 2019;104:319-29. [PMID: 30237274 DOI: 10.3324/haematol.2018.199448] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
42 Karol SE, Yang JJ. Pharmacogenomics and ALL treatment: How to optimize therapy. Semin Hematol 2020;57:130-6. [PMID: 33256902 DOI: 10.1053/j.seminhematol.2020.10.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
43 Rathod S, Ramsey M, DiGiorgio D, Berrios R, Finkelman FD, Fernandez CA. Asparaginase immune complexes induce Fc-γRIII-dependent hypersensitivity in naive mice. FASEB J 2019;33:10996-1005. [PMID: 31284767 DOI: 10.1096/fj.201900857] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
44 Kondyli M, Tremblay DÉ, Rezgui A, Serfaty SA, Gagné V, Ribère M, Laverdière C, Leclerc JM, Tran TH, Sinnett D, Krajinovic M. Human Leucocyte Antigen alleles associated with asparaginase hypersensitivity in childhood Acute Lymphoblastic Leukemia patients treated with Pegylated asparaginase within Dana Farber Cancer Institute treatment protocols. Leuk Res 2021;109:106650. [PMID: 34198115 DOI: 10.1016/j.leukres.2021.106650] [Reference Citation Analysis]
45 Maamari D, El-Khoury H, Saifi O, Muwakkit SA, Zgheib NK. Implementation of Pharmacogenetics to Individualize Treatment Regimens for Children with Acute Lymphoblastic Leukemia. Pharmgenomics Pers Med 2020;13:295-317. [PMID: 32848445 DOI: 10.2147/PGPM.S239602] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
46 Tong H, Phan NVT, Nguyen TT, Nguyen DV, Vo NS, Le L. Review on Databases and Bioinformatic Approaches on Pharmacogenomics of Adverse Drug Reactions. Pharmgenomics Pers Med 2021;14:61-75. [PMID: 33469342 DOI: 10.2147/PGPM.S290781] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
47 Kutszegi N, Gézsi A, F Semsei Á, Müller J, Simon R, Kovács ER, Hegedüs K, Kovács GT, Szalai C, Erdélyi DJ. Two tagging single-nucleotide polymorphisms to capture HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02 haplotype associated with asparaginase hypersensitivity. Br J Clin Pharmacol 2021;87:2542-8. [PMID: 33217039 DOI: 10.1111/bcp.14664] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
48 Pavlovic S, Kotur N, Stankovic B, Zukic B, Gasic V, Dokmanovic L. Pharmacogenomic and Pharmacotranscriptomic Profiling of Childhood Acute Lymphoblastic Leukemia: Paving the Way to Personalized Treatment. Genes (Basel) 2019;10:E191. [PMID: 30832275 DOI: 10.3390/genes10030191] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
49 Liu S, Gao C, Wu Y, Lin W, Li J, Xue T, Wang L, Zheng H, Zhang R. HLA-DRB1*16:02 is associated with PEG-asparaginase hypersensitivity. Pharmacogenomics 2021;22:1135-42. [PMID: 34747637 DOI: 10.2217/pgs-2021-0107] [Reference Citation Analysis]
50 Gomes ER, Kuyucu S. Epidemiology and Risk Factors in Drug Hypersensitivity Reactions. Curr Treat Options Allergy 2017;4:239-57. [DOI: 10.1007/s40521-017-0128-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
51 Højfeldt SG, Wolthers BO, Tulstrup M, Abrahamsson J, Gupta R, Harila-Saari A, Heyman M, Henriksen LT, Jónsson ÒG, Lähteenmäki PM, Lund B, Pruunsild K, Vaitkeviciene G, Schmiegelow K, Albertsen BK; Nordic Society of Paediatric Haematology Oncology (NOPHO) group. Genetic predisposition to PEG-asparaginase hypersensitivity in children treated according to NOPHO ALL2008. Br J Haematol 2019;184:405-17. [PMID: 30450575 DOI: 10.1111/bjh.15660] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
52 Kutszegi N, Yang X, Gézsi A, Schermann G, Erdélyi DJ, Semsei ÁF, Gábor KM, Sági JC, Kovács GT, Falus A, Zhang H, Szalai C. HLA-DRB1*07:01-HLA-DQA1*02:01-HLA-DQB1*02:02 haplotype is associated with a high risk of asparaginase hypersensitivity in acute lymphoblastic leukemia. Haematologica 2017;102:1578-86. [PMID: 28596278 DOI: 10.3324/haematol.2017.168211] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]